GRCL
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
GRCL
Delisted
GRCL was delisted on the 21st of February, 2024.
33 hedge funds and large institutions have $56.3M invested in Gracell Biotechnologies Inc. American Depositary Shares in 2023 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
33
Holders Change
–
Holders Change %
0%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
12
Reduced
8
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
$4.39M |
2 |
O
OrbiMed
New York
|
$17.7M |
3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
$5.86M |
4 |
VC
Vivo Capital
Palo Alto,
California
|
$2.72M |
5 |
SSA
Schonfeld Strategic Advisors
New York
|
$1.14M |